How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC

Published:2022-04 Issue: Volume:237 Page:108962
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Chen Li,Jiang Xiaoying,Li Yuanheng,Zhang Qiqi,Li Qing,Zhang Xiaoyan,Zhang Meng,Yu Qiongfang,Gao Dian

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference240 articles.

1. Cancer Facts & Figures 2019 American Cancer Society,2019

2. Global Cancer Facts & Figures 4th Edition American Cancer Society,2018

3. Colorectal cancer: metastases to a single organ;Vatandoust;World J Gastroenterol,2015

4. Outcome after pulmonary metastasectomy: analysis of 5 years consecutive surgical resections 2002-2006;Hornbech;J Thorac Oncol,2011

5. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies;Simmonds;Br J Cancer,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Nuclear Receptor Coactivator SRC‐1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD‐L1;Advanced Science;2024-07-02

2. Unveil the mechanism for EHMT -- A novel triterpenoid inhibits proliferation and induces apoptosis in colon cancer through ROS-mediated JNK signaling pathway;Biomedicine & Pharmacotherapy;2024-05

3. Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy;Cancer Immunology, Immunotherapy;2024-04-02

4. WTAP‐induced N⁶‐methyladenosine of PD‐L1 blocked T‐cell‐mediated antitumor activity under hypoxia in colorectal cancer;Cancer Science;2024-03-20

5. Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations;Translational Oncology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3